Free Cash Flow Chart

View Free Cash Flow for ATAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -134.54M
March 31, 2026 -115.08M
December 31, 2025 -112.10M
September 30, 2025 -73.67M
June 30, 2025 -69.92M
March 31, 2025 -76.86M
September 30, 2024 -79.87M
June 30, 2024 -78.30M
March 31, 2024 -85.29M
Date Value
December 31, 2023 -84.26M
September 30, 2023 -95.10M
June 30, 2023 -102.00M
March 31, 2023 -99.90M
December 31, 2022 -102.39M
September 30, 2022 -89.89M
June 30, 2022 -92.17M
March 31, 2022 -69.59M
December 31, 2021 -62.25M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Eli Lilly & Co. 13.56B
GH Research Plc -52.46M
Johnson & Johnson 22.61B
Merck & Co., Inc. 16.06B
Zoetis, Inc. 2.366B